Viemed Healthcare Announces 2022 Financial Results
LAFAYETTE, La., March 02, 2023 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, today reported its financial results for the three months and year ended December 31, 2022.
Related news for (VMD)
- Viemed Healthcare Announces Share Repurchase Program
- Revolution Medicines Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating Daraxonrasib in Previously Treated Patients with RAS Mutant Non-Small Cell Lung Cancer
- Viemed Healthcare Announces First Quarter 2025 Financial Results
- Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting
- Viemed Healthcare Announces Record 2024 Financial Results